Current role
Biotechnology · Healthcare
Board Member
2023-09-08–present
David P. Schenkein
Board Member
Regeneron Pharmaceuticals, Inc. (REGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get REGN alertsAbout David P. Schenkein
David P. Schenkein is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN) since September 8, 2023. Regeneron Pharmaceuticals, Inc. reported in an 8-K filed September 8, 2023 that David P. Schenkein was appointed Class II director, effective September 8, 2023. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.
“On September 8, 2023, Regeneron’s board of directors (the “Board”) elected Kathryn Guarini, Ph.D. as a Class III director and David P. Schenkein, M.D. as a Class II director to fill the two vacancies on the Board.”
Affiliation history
-
Current
2023-09-08–present
Company network
Leadership on record at Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos, M.D., Ph.D. Chairman
- Leonard S. Schleifer, M.D., Ph.D. Chairman
- Joseph J. LaRosa General Counsel
- Christine A. Poon Board Member
- Craig B. Thompson, M.D. Board Member
- David P. Schenkein, M.D. Board Member
- Huda Y. Zoghbi, M.D. Board Member
- Joseph L. Goldstein, M.D. Board Member
- Kathryn Guarini Board Member
- Kathryn Guarini, Ph.D. Board Member